ÂÜÀòÂÒÂ×

Suzanne Hendrix is the President and CEO of Pentara Corporation, a company that provides consulting services to pharmaceutical companies and non-profit or academic groups in the field of Alzheimer's disease clinical study design and analysis. With a background in biostatistics, Suzanne has held various leadership positions in companies like Myriad Genetics, Myriad Pharmaceuticals, and Women's Research Institute of BYU. Suzanne's extensive experience includes roles as a researcher, instructor, and biostatistician in a range of pharmaceutical and research institutions. Suzanne holds a Master of Science and Ph.D. in Mathematics and Statistics from Boston University and a Bachelor of Science in Statistics from Brigham Young University.